CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,614
- in 3 filings
Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-21 | Militello John See Remarks | Sale | −2,490 | $28.10 | $70K | 55,239 |
| 2024-02-29 | Militello John See Remarks | Option exercise | +10,000 | $12.55 | $126K | 31,517 |
| 2024-02-29 | Militello John See Remarks | Sale | −10,000 | $29.85 | $298K | 21,517 |
| 2024-02-29 | Militello John See Remarks | Option exercise · Stock Option (Right to Buy) | −10,000 | $12.55 | $126K | 0 |
| 2024-02-29 | Wilson Martin General Counsel | Sale | −4,100 | $29.33 | $120K | 18,680 |
| 2024-02-16 | Wilson Martin General Counsel | Sale | −3,576 | $29.84 | $107K | 6,136 |
| 2024-02-16 | Wilson Martin General Counsel | Grant or award | +16,644 | 22,780 | ||
| 2024-02-16 | Wilson Martin General Counsel | Grant or award · Stock Option (Right to Buy) | +49,091 | 49,091 | ||
| 2024-02-16 | Patel Kinnari See Remarks | Sale | −7,132 | $29.84 | $213K | 238,346 |
| 2024-02-16 | Patel Kinnari See Remarks | Grant or award | +33,288 | 271,634 | ||
| 2024-02-16 | Patel Kinnari See Remarks | Grant or award · Stock Option (Right to Buy) | +98,183 | 98,183 | ||
| 2024-02-16 | Militello John See Remarks | Sale | −3,238 | $29.84 | $97K | 13,195 |
| 2024-02-16 | Militello John See Remarks | Grant or award | +8,322 | 21,517 | ||
| 2024-02-16 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +24,545 | 24,545 | ||
| 2024-02-16 | White Mark Andrew Chief Medical Officer | Grant or award | +11,096 | 87,758 | ||
| 2024-02-16 | White Mark Andrew Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +32,727 | 32,727 | ||
| 2024-02-16 | Shah Gaurav CEO | Sale | −20,272 | $29.84 | $605K | 554,762 |
| 2024-02-16 | Shah Gaurav CEO | Grant or award | +66,577 | 621,339 | ||
| 2024-02-16 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +196,336 | 196,336 | ||
| 2024-02-14 | Wilson Martin General Counsel | Option exercise | −9,712 | 9,712 |
Page 12 of 19 · 374 trades